Specialty pharmacy data is distinct from traditional PRx data because it covers a narrower but clinically significant patient population. Specialty drugs, including biologics, oncology therapies and rare disease treatments, are often only available through limited distribution networks or exclusive specialty pharmacy hubs. SP data captures dispensing, patient support program enrollment, adherence and persistence patterns for these therapies, making it essential for launch tracking and patient journey analysis in complex disease areas.